Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Autoimmune Disorders

  Free Subscription


23.06.2025

1 BMC Neurol
1 Curr Opin Immunol
3 Intern Med
2 J Autoimmun
3 J Clin Endocrinol Metab
1 J Nephrol
9 Mult Scler
1 N Engl J Med
1 Neurologia (Engl Ed)
1 Neurology
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Neurol

  1. SHAABAN S, Kishk NA, Nawito A, Hamdy A, et al
    New-onset drug-resistant epilepsy in type 1 diabetes mellitus patient following COVID-19 vaccination: suspicious for autoimmune pathogenesis.
    BMC Neurol. 2025;25:251.
    PubMed         Abstract available


    Curr Opin Immunol

  2. ZHOU W, Zhang B, Zhao M, Lu Q, et al
    Epigenetics: the link between environmental exposures and autoimmune diseases.
    Curr Opin Immunol. 2025;95:102592.
    PubMed         Abstract available


    Intern Med

  3. SUZUKI E, Matsumoto H, Yoshida S, Saito K, et al
    Idiopathic Multicentric Castleman Disease Diagnosed after Lower Extremity Venous Thrombosis Mimicking Immunoglobulin G4-related Disease.
    Intern Med. 2025;64:1911-1917.
    PubMed         Abstract available

  4. NISHI R, Koike H, Maekawa T, Nakamura Y, et al
    Positive Antiganglioside Antibodies in a Patient with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System.
    Intern Med. 2025;64:1893-1899.
    PubMed         Abstract available

  5. ANDO M, Nagase H, Shibata T, Yamatani I, et al
    Secondary Membranous Nephropathy Associated with Mycobacterium intracellulare.
    Intern Med. 2025 Jun 19. doi: 10.2169/internalmedicine.5527.
    PubMed         Abstract available


    J Autoimmun

  6. RENAUDINEAU Y, Sposito F, Natoli V, Charras A, et al
    Common Toll-like receptor 7 variants define disease risk and phenotypes in juvenile-onset systemic lupus erythematosus.
    J Autoimmun. 2025;155:103451.
    PubMed         Abstract available

  7. SAKSAGER AB, Hede FD, Barra C
    Autoimmune associated HLAs and T cell autoantigens exhibit common patterns across several autoimmune diseases.
    J Autoimmun. 2025;155:103443.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  8. WANG S, Zhang Y, Balati A, Li B, et al
    Effect of Sodium-Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    J Clin Endocrinol Metab. 2025 Jan 15:dgaf016. doi: 10.1210.
    PubMed         Abstract available

  9. DICKENS LT, Gonzalez MG
    Approach to the Patient using Diabetes Technology in Pregnancy.
    J Clin Endocrinol Metab. 2025 Jan 7:dgae914. doi: 10.1210.
    PubMed         Abstract available

  10. JOHNSON RJ, Bergford S, Gal RL, Calhoun P, et al
    The Role of Whole Food Plant-Based Food Intake on Postprandial Glycemia in Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Oct 18:dgae725. doi: 10.1210.
    PubMed         Abstract available


    J Nephrol

  11. DECAESTECKER A, Daniel A, Malbranque Z, Wayolle N, et al
    Crescentic glomerulonephritis associated with myelodysplatic syndrome and visceral leishmaniasis.
    J Nephrol. 2025 Jun 19. doi: 10.1007/s40620-025-02329.
    PubMed         Abstract available


    Mult Scler

  12. BEREK K, Schmidauer M, Bsteh G, Auer M, et al
    Kappa free light chain index predicts long-term disease activity and disability accrual in multiple sclerosis.
    Mult Scler. 2025 Jun 16:13524585251344807. doi: 10.1177/13524585251344807.
    PubMed         Abstract available

  13. SAHU M, Chomba M, Mortel D, Braun S, et al
    Factors associated with delay to diagnosis of multiple sclerosis in Zambia.
    Mult Scler. 2025 Jun 17:13524585251344832. doi: 10.1177/13524585251344832.
    PubMed         Abstract available

  14. ARAB BAFRANI M, Rios V, Kim MJ, Balan A, et al
    Gynecological health: A missing link in comprehensive treatment monitoring for multiple sclerosis.
    Mult Scler. 2025 Jun 18:13524585251346371. doi: 10.1177/13524585251346371.
    PubMed         Abstract available

  15. PORTACCIO E, Betti M, De Meo E, Pasto L, et al
    Age-dependent response to initial highly effective treatment in relapsing multiple sclerosis.
    Mult Scler. 2025 Jun 19:13524585251345317. doi: 10.1177/13524585251345317.
    PubMed         Abstract available

  16. ARNOLD DL, Kolind S, Assemlal HE, Bar-Or A, et al
    Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS.
    Mult Scler. 2025;31:821-832.
    PubMed         Abstract available

  17. LEAVITT VM, Fox R, Mostert J, D'Haeseleer M, et al
    Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study.
    Mult Scler. 2025;31:866-876.
    PubMed         Abstract available

  18. GARTHOF S, Schafer S, Elmers J, Schwed L, et al
    Speech as a digital biomarker in multiple sclerosis: Automatic analysis of speech metrics using a multi-speech-task protocol in a cross-sectional MS cohort study.
    Mult Scler. 2025;31:856-865.
    PubMed         Abstract available

  19. VUKUSIC S, Hubben F, Gavoille A, Malek Y, et al
    Beyond the switch to the biosimilar of natalizumab: What is the impact of changing the JCV test?
    Mult Scler. 2025;31:877-881.
    PubMed         Abstract available

  20. VARLEY J, Beyrouti R, Nicholas R, Dorsey R, et al
    A comparison of JC virus assay performance provided with originator and biosimilar natalizumab.
    Mult Scler. 2025;31:882-885.
    PubMed         Abstract available


    N Engl J Med

  21. WOLFE GI, Shelly S
    Myasthenia Gravis - Redemption for B-Cell Depletion.
    N Engl J Med. 2025;392:2382-2384.
    PubMed        


    Neurologia (Engl Ed)

  22. CAYUELA L, Garcia-Munoz C, Sainz de la Maza S, Cayuela A, et al
    Prevalence of multiple sclerosis in Spain. Estimates from the Primary Care Clinical Database (BDCAP).
    Neurologia (Engl Ed). 2025;40:447-455.
    PubMed         Abstract available


    Neurology

  23. WU L, Jiang W, Du R, Liu Y, et al
    Clinical Reasoning: Acute and Progressive Cognitive Decline in a 38-Year-Old Man.
    Neurology. 2025;105:e213871.
    PubMed         Abstract available


    PLoS One

  24. BLOIS SL, Cuq BY, Bienzle D
    Lymphocyte immunophenotype in dogs with immune-mediated hematologic disease.
    PLoS One. 2025;20:e0326341.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  25. ATKINSON KC, Desfor S, Feri M, Sekyi MT, et al
    Decreased mitochondrial activity in the demyelinating cerebellum of progressive multiple sclerosis and chronic EAE contributes to Purkinje cell loss.
    Proc Natl Acad Sci U S A. 2025;122:e2421806122.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.